WHO announces start of Ebola vaccine clinical trial in DR Congo
A clinical trial begins to test the safety, efficacy and immunogenicity of multiple vaccines.
International news in seven languages
Topic
A clinical trial begins to test the safety, efficacy and immunogenicity of multiple vaccines.
The scientists involved say the results could mark a turning point in cancer treatment, bringing personalised medicine a step closer.
The heads of the International Monetary Fund, World Bank Group, World Health Organization and World Trade Organization held on 9 November the 2nd High-Level Consultations with the CEOs of leading COVID-19 vaccine manufacturing companies. At the meeting, all participants agreed on the urgency of delivering more vaccine doses to low-income countries, where less than 2.5% of the population has been fully vaccinated.
The town of Masaka in southern Uganda is currently conducting a Phase 1 trial of a vaccine candidate against the Bundibugyo strain of the Ebola virus, which is circulating in the region. There is currently no approved treatment or vaccine for this strain.
Ministers promise to reform the scheme that provides financial support for those injured or bereaved by vaccines in the UK.
A twice-yearly injection could revolutionise HIV prevention, but who gets access raises bigger questions.
COVID-19 vaccine maker BioNTech is to close three sites in Germany after efforts to find buyers failed. Meanwhile, Rhine water levels have fallen to record lows after an unusually dry September. DW has more.
50,000 frontline staff to receive a jab for a different Ebola strain, with 20,000 enrolled in a one-year clinical trial.
Cambridge scientists say they have, for the first time, tested a vaccine designed by AI.
The UK medicines regulator has given approval for an experimental vaccine to be tested on healthy adults.
The cost of administration and medical checks has now topped £83m, according to new figures.